Cite
HARVARD Citation
Toth, P. et al. (2015). Impact of lomitapide and lomitapide/ezetimibe combination therapy on low-density lipoprotein subfractions and risk marker ratios. Atherosclerosis. 241 (1), pp. e203-e204. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toth, P. et al. (2015). Impact of lomitapide and lomitapide/ezetimibe combination therapy on low-density lipoprotein subfractions and risk marker ratios. Atherosclerosis. 241 (1), pp. e203-e204. [Online].